Cancer
New Dog Breed is Oncologist’s New Best Friend
By Kimberly Lord Stewart A new breed of dog, which is loyal and highly trainable with a keen sense of smell, may be the next tool for early cancer detection. The Russian airline Aeroflot and an R&D group have patented the Sulimov dog breed for airport security purposes but realizeRead
Aspirin Reduces Cervical Cancer Risk by 47%
Frequent intake of aspirin may cut cervical cancer risk by half, according to a study led by researchers at Roswell Park Cancer Institute (RPCI). Frequent intake was defined by five or more years of use of 7 or more tablets per week. According to the American Cancer Society, 12,900 newRead
Research Review of Curcumin
Communicating with Patients About Dietary Supplement Use
The use of dietary supplements among patients affected by cancer is extensive, with an estimated 20-90 % of patients using these products. Their use of these products is often not shared with the treating physician. “Doctors need to understand why patients with cancer use dietary supplements in the first place. Patients tend to use these supplements because they want to do everything possible to feel hopeful, empower themselves, enhance the body’s natural defenses, use less toxic treatments, or reduce side effects of mainstream treatments,” said Dr. Victor Sierpina, UTMB professor of family medicine. “In fact, most patients choose to use dietary supplements to improve their quality of life rather than seeking a cure for their disease.” In the September issue of Current Oncology Reports, researchers at University of Texas Medical Branch, Sierpina describes a patient centered approach to managing dietary supplement use in cancer care. By Moshe Frenkel and Victor Sierpina, published in Current Oncology, Sept. 2014.
Human Clinical: Selenium Yeast Reduces Oxidative Stress In Men
For the first time ever, researchers have made a significant positive connection between biomarkers of oxidative sress, a standardized form of selenium-enriched yeast and reduced prostate cancer risk. Results from long-term clinical trial suggest that selenium-enriched yeast (SY), in a dose-dependent, standardized form from SelenoExcell, but not selenomethionine (SeMet) may be effective at reducing prostate cancer risk. This study confirmed reductions in biomarkers of oxidative stress following supplementation with the standardized form of SY but not SeMet in healthy men. By John P Richie Jr PhD, Karam el-Bayoumy PhD et al, published in Cancer Prevention Research, August 2014.
Integrative Psychiatry Effective but Overlooked for Cancer Patients
Nearly three-quarters of cancer patients who have major depression are not currently receiving treatment for depression, and that a new integrated treatment programme is strikingly more effective at reducing depression and improving quality of life than current care, according to three papers published in The Lancet Psychiatry, The Lancet, and The Lancet Oncology. Lead author Professor Michael Sharpe from the University of Oxford in the UK, says “The huge benefit that DCPC delivers for patients with cancer and depression shows what we can achieve for patients if we take as much care with the treatment of their depression as we do with the treatment of their cancer.” By M Sharpe, et al., published in the Lancet and Lancet Oncology, Aug. 2014.
Case Study: Escharotic Treatment for ECC-positive Cervical Epithelial Neoplasia in Childbearing Years
Inactivity Linked to Colon, Lung, Endometrial Cancer
It is widely accepted that physical inactivity leads to weight gain, cardiovascular disease and diabetes. New research links a sedentary lifestyle to certain cancers, specifically colon, lung and endometrial cancer, according to a study published June 16 in the JNCI: Journal of the National Cancer Institute. The research is significance as is shows sedentary behavior is emerging as an independent risk factor for cancer, chronic disease and mortality. However, in a clinical setting guidelines to improve activity levels for adult patients are poorly defined and difficult to implement.
Breast Cancer and DNA Repair Capacity: Multivitamin & Calcium Supplements
Breast cancer (BC) is the most common cancer in women, with over 1 million new cases diagnosed
every year worldwide. Over recent decades, considerable interest has emerged regarding whether vitamins and/or other supplements can lower the risk of BC. However, previous epidemiologic studies that investigated the association between intake of multivitamin and supplements of single vitamins and minerals and BC risk have reported conflicting results. Whether vitamins can actually reduce BC risk is still controversial. This study examined whether multivitamin and calcium use was associated with BC incidence and DNA repair capacity (DRC).
Vitamin D May Improve Breast Cancer Survival
